https://doi.org/10.4081/monaldi.2021.1828
Intermittent abdominal pressure ventilation: feasibility and efficacy in neuromuscular disease. A case report
Submitted: March 1, 2021
Accepted: May 30, 2021
Published: August 3, 2021
Accepted: May 30, 2021
Abstract Views: 1112
PDF: 473
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
The standard treatment for patients with neuromuscular respiratory failure is non-invasive ventilation (NIV) as non-invasive ventilation support-setting (NVS). NVS is administered through a nasal or face mask and/or mouthpiece with the potential to cause nasal ulcers, discomfort, and/or aesthetic issues, resulting in poor compliance. We reported the observation of a 45-year-old woman with limb-girdle muscular dystrophy (LGMD), secondary to Dysferlin deficiency, who was on NVS since 2017 for nocturnal hypoventilation. In 2018, despite nocturnal ventilation, due to weight gain and daytime hypoventilation, a nasal mask was introduced. We initiated daytime intermittent abdominal pressure ventilation (IAPV) to mitigate cosmetic problems, improving in pO2 and decreasing in pCO2 versus baseline (52>84 mmHg, 46>33 mmHg respectively) at 6 (85 mmHg, 42 mmHg) and 18 months (93 mmHg, 38 mmHg), respectively. IAPV was effective, safe, and well-tolerated in our patients who did not tolerate standard daytime NVS with the known interface.
Hess DR. Noninvasive ventilation in neuromuscular disease: equipment and application. Respir Care 2006;51:896-911; discussion 911-2.
Fiorentino G, Annunziata A, Gaeta AM, et al. Continuous noninvasive ventilation for respiratory failure in patients with amyotrophic lateral sclerosis: current perspectives. Degener Neurol Neuromuscul Dis 2018;8:55-61.
DOI: https://doi.org/10.2147/DNND.S170771
Bach JR, Alba AS. Intermittent abdominal pressure ventilator in a regimen of noninvasive ventilatory support. Chest 1991;99:630-6.
DOI: https://doi.org/10.1378/chest.99.3.630
Cardus D, Vallbona C, Spencer WA. Effects of three kinds of artificial respirators on the pulmonary ventilation and arterial blood of patients with chronic respiratory insufficiency. Dis Chest 1966;50:297-306.
DOI: https://doi.org/10.1378/chest.50.3.297
Windisch W, Dreher M, Geiseler J, et al. Guidelines for non-invasive and invasive home mechanical ventilation for treatment of chronic respiratory failure - Update 2017. Pneumologie 2017;71:722-95.
Rochwerg B, Brochard L, Elliott MW, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J 2017;50: 1602426.
DOI: https://doi.org/10.1183/13993003.02426-2016
Yang GF, Alba A, Lee M, Khan A. Pneumobelt for sleep in the ventilator user: clinical experience. Arch Phys Med Rehabil 1989;70:707-11.
Seliger GM, Zackson H, Nichols L, et al. Neurological improvement following respiratory support in syringomyelia: case report. Paraplegia 1990;28:526-8.
DOI: https://doi.org/10.1038/sc.1990.70
Banfi PI, Volpato E, Bach JR. Efficacy of new intermittent abdominal pressure ventilator for post-ischemic cervical myelopathy ventilatory insufficiency. Multidiscip Respir Med 2019;14:4.
DOI: https://doi.org/10.4081/mrm.2019.7
De Mattia E, Iatomasi M, Garabelli B, et al. Use of the intermittent abdominal pressure ventilation to guarantee speech in a tracheostomized amyotrophic lateral sclerosis patient. Rev Port Pneumol (2006) 2017; 23236-9.
Hill NS. Clinical applications of body ventilators. Chest 1986;90:897-905.
DOI: https://doi.org/10.1378/chest.90.6.897
Balestroni G, Bertolotti G. [EuroQol-5D (EQ-5D): an instrument for measuring the quality of life].[Article in Italian]. Monaldi Arch Chest Dis 2012;78:155-9.
No authors listed. The world health organization quality of life assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 1998;46:1569-85.
DOI: https://doi.org/10.1016/S0277-9536(98)00009-4
Rights
The authors have obtained the written informed consent of the patient mentioned in the article to collect her data and share her photo. The corresponding author is in possession of the written informed consent.How to Cite
Puricelli, Cristina, Eleonora Volpato, Salvatore Sciurello, Antonello Nicolini, and Paolo Banfi. 2021. “Intermittent Abdominal Pressure Ventilation: Feasibility and Efficacy in Neuromuscular Disease. A Case Report”. Monaldi Archives for Chest Disease 91 (4). https://doi.org/10.4081/monaldi.2021.1828.
Copyright (c) 2021 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Morgan Daniel, Charles Ricordel, Aurélien Lorleac'h, James Norwood, Bertrand Richard De Latour, Simon Rouzé, Jean-Philippe Verhoye, The illusion of a chest wall tumor: a case-report of sternal tuberculosis , Monaldi Archives for Chest Disease: Vol. 92 No. 4 (2022)
- Brandon Iturbe Esquivel, José Meneses Calderón, Luis Edgar Concepción Carrillo, Hugo Mendieta Zeron, Rural treatment of COVID-19 patients with pirfenidone, nitazoxanide and colchicine. Case series , Monaldi Archives for Chest Disease: Vol. 93 No. 1 (2023)
- Lucrezia De Michele, Paola Pierucci, Guido Giovannetti, Michele De Ceglie, Michela Dimitri, Alessandra Mirabile, Vitaliano Quaranta, Arnaldo Scardapane, Carlo D'Agostino, Giovanna Elisiana Carpagnano, Post severe COVID-19 infection lung damages study. The experience of early three months multidisciplinary follow-up , Monaldi Archives for Chest Disease: Vol. 92 No. 4 (2022)
- Tarun Krishna Boppana, Saurabh Mittal, Karan Madan, Anant Mohan, Vijay Hadda, Randeep Guleria, Tocilizumab for COVID-19: A systematic review and meta-analysis of randomized controlled trials , Monaldi Archives for Chest Disease: Vol. 92 No. 4 (2022)
- Shivam Garg, Pratap Upadhya, Arul Kumar, Norton Stephen, Bala Subramanian, Overcoming the challenges of a misdiagnosed rare lung disease – idiopathic pleuroparenchymal fibroelastosis , Monaldi Archives for Chest Disease: Vol. 94 No. 2 (2024)
- Marco Umberto Scaramozzino, Maurizia Festa, Guido Levi, Ubaldo Romeo Plastina, Giovanni Sapone, Correlation between gastroesophageal reflux disease lung volumes and exacerbation of bronchial asthma: Italian pilot observational retrospective study GERDAS , Monaldi Archives for Chest Disease: Vol. 94 No. 2 (2024)
- Marco Umberto Scaramozzino, Guido Levi, Ubaldo Romeo Plastina, Giovanni Sapone, A rare case of asthmatic patient with left Chilaiditi’s syndrome , Monaldi Archives for Chest Disease: Early Access
- Danilo Buonsenso, Davide Pata, Arianna Turriziani Colonna, Vittoria Ferrari, Gilda Salerno, Piero Valentini, Vitamin D and tuberculosis in children: a role in the prevention or treatment of the disease? , Monaldi Archives for Chest Disease: Vol. 92 No. 4 (2022)
- Fulvio Cacciapuoti, Antonio D’Onofrio, Luca Gaetano Tarquinio, Valentina Capone, Ciro Mauro, Raffaele Marfella, Federico Cacciapuoti, Sleep-disordered breathing and heart failure: a vicious cycle of cardiovascular risk , Monaldi Archives for Chest Disease: Vol. 94 No. 2 (2024)
- Pankti Sheth, Shibdas Chakrabarti, Neeraj Kumar Gupta, Pranav Ish, Rohit Kumar, Nitesh Gupta, A middle-aged lady with near-fatal respiratory failure , Monaldi Archives for Chest Disease: Vol. 92 No. 3 (2022)
<< < 69 70 71 72 73 74 75 > >>
You may also start an advanced similarity search for this article.
